# An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)

> **NCT01814020** · PHASE2 · COMPLETED · sponsor: **Moberg Pharma AB**

## Conditions studied

- Distal Subungual Onychomycosis

## Interventions

- **DRUG:** MOB015B

## Key facts

- **NCT ID:** NCT01814020
- **Lead sponsor:** Moberg Pharma AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** — (—)
- **Last updated:** 2014-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01814020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01814020, "An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01814020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*